pandem
caus
novel
coronaviru
result
global
health
econom
crisi
unpreced
scale
high
transmiss
combin
lack
popul
immun
preval
sever
clinic
outcom
urg
rapid
develop
effect
therapeut
countermeasur
report
gener
synthet
nanobodi
known
sybodi
receptorbind
domain
rbd
expediti
process
take
twelv
work
day
sybodi
select
entir
vitro
three
larg
combinatori
librari
use
ribosom
phage
display
obtain
six
strongli
enrich
sybodi
pool
isol
rbd
identifi
uniqu
antirbd
sybodi
also
interact
context
fulllength
spike
protein
anticip
compact
binder
sybodi
could
feasibl
develop
inhal
drug
use
conveni
prophylaxi
moreov
gener
polyval
antivir
via
fusion
antirbd
sybodi
addit
small
binder
recogn
secondari
epitop
could
enhanc
therapeut
potenti
guard
escap
mutant
present
full
sequenc
inform
detail
protocol
identifi
sybodi
freeli
access
resourc
report
updat
character
identifi
sybodi
term
affin
scaledup
purif
yield
potenti
neutral
infect
ongo
pandem
aris
emerg
novel
coronaviru
demand
urgent
develop
effect
antivir
therapeut
sever
factor
contribut
advers
natur
global
health
perspect
includ
absenc
herd
immun
high
transmiss
prospect
asymptomat
carrier
high
rate
clinic
sever
outcom
moreov
vaccin
unlik
avail
least
month
despit
earnest
develop
effort
make
altern
intervent
strategi
paramount
addit
offer
relief
patient
suffer
result
diseas
therapeut
may
also
reduc
viral
transmiss
rate
administ
asymptomat
individu
subsequ
probabl
exposur
final
given
repres
third
global
coronaviru
outbreak
past
year
develop
rapid
therapeut
strategi
current
crise
could
offer
greater
prepared
futur
pandem
akin
coronavirus
viral
envelop
harbor
protrud
clublik
multidomain
spike
protein
provid
machineri
enabl
entri
human
cell
spike
ectodomain
segreg
two
region
term
outer
subunit
respons
host
recognit
via
interact
ctermin
receptorbind
domain
rbd
human
angiotensin
convert
enzym
present
exterior
surfac
airway
cell
known
hostrecognit
role
ntermin
domain
ntd
notabl
ntd
coronavirus
shown
bind
host
surfac
glycan
contrast
spike
region
subunit
contain
membran
fusion
apparatu
also
mediat
trimer
ectodomain
prior
host
recognit
spike
protein
exist
metast
prefus
state
wherein
subunit
lay
atop
region
rbd
oscil
conform
respect
access
inaccess
receptor
bind
receptor
engag
cleavag
subunit
host
proteas
subunit
undergo
dramat
conform
chang
prefus
postfus
state
structur
rearrang
associ
merg
viral
envelop
host
membran
therebi
allow
inject
genet
inform
host
cell
coronaviru
spike
protein
highli
immunogen
sever
experiment
approach
sought
target
molecular
featur
purpos
viral
neutral
high
specif
potenc
modular
natur
antibodybas
antivir
therapeut
shown
except
promis
isol
purifi
rbd
popular
target
develop
antispik
antibodi
pathogen
coronavirus
howev
binder
isol
rbd
may
effect
engag
aforement
prefus
conform
full
spike
could
account
poor
neutral
abil
recent
describ
singledomain
antibodi
rais
rbd
therefor
better
identifi
molecul
qualiti
befit
druglik
candid
would
advantag
valid
rbdspecif
binder
context
full
stabil
prefus
spike
assembl
target
protein
recent
design
three
librari
synthet
nanobodi
term
sybodi
base
elucid
structur
nanobodytarget
complex
fig
sybodi
select
target
protein
within
twelv
work
day
consider
faster
natur
nanobodi
requir
repetit
immun
period
two
month
prior
binder
select
phage
display
fig
consider
advantag
platform
sybodi
select
carri
defin
condit
case
coronaviru
spike
protein
offer
opportun
gener
binder
recogn
metast
prefus
conform
final
due
feasibl
inhal
therapeut
nanobodi
formul
virusneutr
sybodi
could
offer
conveni
direct
mean
prophylaxi
provid
preliminari
report
vitro
select
identif
sybodi
rbd
two
independ
prepar
rbd
construct
use
vitro
sybodi
select
result
singl
clone
could
bind
full
spike
protein
sequenc
present
sequenc
clone
along
detail
protocol
enabl
commun
freeli
produc
character
binder
manuscript
updat
amend
continu
analysi
construct
includ
competit
assay
pseudoviru
neutral
experi
bind
kinet
isol
rbd
well
prefusionstabil
spike
assembl
base
sequenc
align
isol
rbd
variant
amen
purif
crystal
rbd
construct
design
consist
residu
fuse
venu
yfp
rbdvyfp
construct
express
secret
cell
rbdvyfp
extract
directli
cultur
medium
supernat
use
immobil
antigfp
nanobodi
afford
highli
purifi
product
neglig
background
contamin
initi
effort
cleav
ctermin
vyfp
fusion
partner
proteas
result
unstabl
rbd
experi
continu
full
rbdvyfp
fusion
protein
account
presenc
vyfp
fusion
partner
second
rbd
construct
consist
fusion
murin
fc
domain
rbdfc
commerci
acquir
remov
trace
amin
buffer
exchang
pb
via
extens
dialysi
protein
chemic
biotinyl
degre
biotinyl
assess
streptavidin
gelshift
assay
found
greater
target
protein
note
rbd
fusion
protein
wellbehav
commerci
acquir
purifi
fulllength
spike
protein
found
aggregationpron
effort
current
underway
produc
valid
engin
spike
protein
contain
mutat
known
stabil
prefus
state
well
ctermin
trimer
motif
therefor
experi
present
herein
pertain
fullspik
interact
replic
stabil
spike
variant
three
sybodi
librari
concav
loop
convex
start
rbdvyfp
construct
use
ribosom
display
rbdfc
construct
use
two
phage
display
round
select
variant
rbdvyfprbdfcrbdfc
vice
versa
select
variant
rbdfcrbdvyfprbdvyfp
henc
total
six
select
reaction
tabl
fig
increas
averag
affin
isol
sybodi
includ
offrat
select
step
use
preenrich
purifi
sybodi
pool
phage
display
round
competitor
end
sybodi
pool
three
librari
select
variant
subclon
phage
display
vector
sybodi
express
vector
psbinit
subsequ
two
separ
pool
sybodi
select
variant
respect
express
purifi
purifi
pool
ad
pan
reaction
respect
select
variant
second
phage
display
round
therebi
rebind
sybodyphag
complex
fast
offrat
suppress
enrich
sybodi
rbd
monitor
qpcr
alreadi
first
phage
display
round
concav
loop
sybodi
select
variant
show
enrich
factor
respect
tabl
second
phage
display
round
includ
offrat
select
step
strong
enrich
factor
rang
determin
subclon
pool
phage
display
vector
pdxinit
sybodi
express
vector
psbinit
clone
select
reaction
tabl
fig
pick
random
express
small
scale
standard
elisa
perform
use
rbdvyfp
rbd
spike
ectodomain
contain
ecd
maltos
bind
protein
mbp
unrel
dummi
protein
outlin
materi
method
elisa
analysi
reveal
high
hit
rate
rbd
ecd
rang
respect
fig
tabl
major
sybodi
give
elisa
signal
rbd
also
gave
clear
signal
fulllength
spike
protein
fig
howev
total
hit
gave
elisa
signal
rbdvyfp
ecd
could
due
presenc
cryptic
rbd
epitop
access
context
fulllength
spike
protein
respect
sybodi
may
recogn
vyfp
portion
rbdvyfp
construct
though
select
procedur
clearli
disfavor
latter
explan
importantli
background
bind
dummi
protein
mbp
observ
analyz
sybodi
clearli
show
binder
highli
specif
sequenc
sybodi
elisaposit
rbdvyfp
well
fulllength
spike
select
reaction
number
sb
see
also
fig
sequenc
result
sybodi
clone
unambigu
clone
found
uniqu
respect
clone
name
indic
elisa
figur
fig
tabl
note
duplic
binder
identifi
select
variant
indic
two
separ
select
stream
gave
rise
complet
differ
array
sybodi
addit
note
one
sybodi
identifi
suppos
convex
librari
turn
belong
concav
librari
spillov
sybodi
across
librari
occasion
observ
henc
total
concav
loop
convex
sybodi
align
accord
librari
origin
final
analysi
sybodi
sequenc
align
gener
phylogenet
tree
show
clear
segreg
across
three
librari
indic
larg
sequenc
variabl
identifi
sybodi
fig
demonstr
abil
rapid
vitro
select
platform
gener
sybodi
rbd
within
twoweek
timefram
anticip
present
panel
antirbd
sybodi
could
use
design
urgent
requir
therapeut
mitig
pandem
particularli
develop
inhal
prophylact
formul
attempt
provid
complet
account
gener
molecul
includ
full
sequenc
detail
method
research
may
contribut
ongo
analysi
current
engag
addit
character
sybodi
includ
affin
determin
competit
analysi
pseudoviru
neutral
assay
provid
updat
manuscript
new
data
acquir
furthermor
test
antirbd
sybodi
interact
full
wildtyp
spike
protein
rescreen
select
pool
engin
spike
variant
stabli
maintain
trimer
prefus
conform
longerterm
outlook
sybodi
result
futur
select
campaign
target
addit
spike
epitop
coupl
present
antirbd
sybodi
gener
polyval
construct
multispecif
design
may
crucial
evas
escap
mutant
final
recent
describ
flycod
technolog
employ
deeper
interrog
select
pool
order
facilit
discoveri
except
sybodi
possess
low
offrat
recogn
rare
epitop
gene
encod
residu
rbd
genbank
access
downstream
modifi
ntermin
human
serum
albumin
secret
signal
chemic
synthes
geneunivers
gene
subclon
use
fx
technolog
custom
mammalian
express
vector
append
ctermin
proteas
cleavag
site
myc
tag
venu
yfp
streptavidinbind
peptid
onto
open
read
frame
rbdvyfp
ml
suspensionadapt
cell
thermo
transient
transfect
use
expifectamin
accord
manufactur
protocol
thermo
express
continu
day
humidifi
environ
cell
pellet
min
cultur
supernat
filter
mesh
size
pass
three
time
graviti
column
contain
nhsagaros
bead
coval
coupl
antigfp
nanobodi
resin
cultur
ratio
resin
per
express
cultur
resin
wash
columnvolum
rbd
buffer
phosphatebuff
salin
ph
supplement
addit
nacl
rbdvyfp
elut
glycin
ph
via
sequenti
ml
fraction
without
prolong
incub
resin
acid
elut
buffer
fraction
tube
prefil
vol
tri
ph
elut
fraction
immedi
phneutral
fraction
contain
rbdvyfp
pool
concentr
store
puriti
estim
base
sdspage
shown
yield
rbdvyfp
approxim
per
ml
express
cultur
second
purifi
rbd
construct
consist
residu
fuse
murin
fc
domain
rbdfc
express
cell
purchas
sino
biolog
catalogu
number
order
purifi
fulllength
spike
ectodomain
ecd
compris
residu
ctermin
histag
express
baculovirusinsect
cell
purchas
sino
biolog
catalogu
number
order
remov
amin
protein
first
extens
dialyz
rbd
buffer
protein
concentr
use
amicon
ultra
concentr
unit
molecular
weight
cutoff
kda
subsequ
protein
chemic
biotinyl
min
use
nhsbiotin
thermo
fisher
ad
molar
excess
target
protein
immedi
sampl
dialyz
tb
ph
process
first
dialysi
concentr
biotinyl
second
dialysi
rbdvyfp
rbdfc
ecd
respect
lost
due
stick
concentr
filter
due
aggreg
biotinyl
sampl
dilut
tb
glycerol
store
small
aliquot
sybodi
select
three
sybodi
librari
concav
loop
convex
carri
describ
detail
short
one
round
ribosom
display
follow
two
round
phage
display
carri
binder
select
two
differ
construct
rbd
rbdvyfp
fusion
rbdfc
fusion
mbp
use
background
control
determin
enrich
score
qpcr
order
avoid
enrich
binder
fusion
protein
yfp
fc
switch
two
target
ribosom
display
fig
offrat
select
use
nonbiotinyl
target
protein
describ
standard
protocol
enough
purifi
protein
hand
instead
subclon
three
librari
select
first
round
phage
display
psbinit
vector
clone
express
six
pool
e
coli
cell
pool
correspond
select
pool
purif
two
final
pool
purifi
ninta
resin
use
graviti
flow
column
follow
buffer
exchang
main
peak
fraction
use
desalt
column
tb
ph
remov
imidazol
pool
elut
ml
instead
ml
tb
ph
order
ensur
complet
buffer
exchang
two
purifi
pool
use
offrat
select
second
round
phage
display
concentr
approxim
select
variant
rbpfc
select
variant
rbpyfp
volum
use
offrat
select
pool
use
offrat
select
bsa
ad
sampl
offrat
select
perform
minut
elisa
perform
describ
detail
singl
clone
analyz
librari
select
sinc
rbdfc
construct
incompat
elisa
format
due
inclus
protein
captur
antibodi
elisa
perform
rbdvyfp
nm
ecd
nm
neg
control
assess
background
bind
sybodi
use
biotinyl
mbp
nm
posit
elisa
hit
sequenc
microsynth
switzerland
sb
belong
concav
librari
spillov
two
sequenc
reaction
fail
current
unabl
ship
plasmid
purifi
protein
analyz
identifi
sybodi
make
highest
affin
binder
avail
addgen
take
week
avail
pleas
feel
free
synthes
sybodi
gene
base
protein
sequenc
provid
six
independ
selec
reac
on
clone
pick
random
analyz
elisa
nonrandom
sybodi
use
nega
control
well
respec
veli
sybodi
sequenc
mark
respec
sybodi
name
sb
pleas
note
iden
cal
sybodi
found
me
mark
sybodi
name
eg
sb
concav
adsvkgrftisrdnakntvylqmnslkpedtavyycxvxvgxxyxgqgtqvtv
phylogen
c
tree
rbd
sybodi
radial
tree
gener
clc
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doiorg
